Glen Eagle Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-110	Closed	-$8.77K	–	633
2017 Q2	$8.77K	Sell	110 -110	-50%	-$8.77K	0.01%	410
2017 Q1	$11.3K	Buy	+220	New	+$11.3K	0.01%	352